SEC 13F Intelligence

Managers / Q1 2020 · view latest →

ARMISTICE CAPITAL, LLC

CIK 0001601086 · 510 MADISON AVENUE, 7TH FLOOR, NEW YORK, NY, 10022 · (212) 231-4932

Reported Value
$1.6B
Q1 2020
Positions
79
Filings on Record
26
2019–present window
Filed
May 15, 2020
original filing

Summary

Armistice Capital, LLC reported $1.6B in U.S.-listed holdings across 79 positions for Q1 2020.

Its largest position, Cerecor, represents 4.3% of the portfolio.

Portfolio Metrics

Top-10 Concentration
+28.0%
share of reported value
Largest Position
+4.3%
Cerecor

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’20: $1.6BQ1 ’20Q2 ’20: $2.3BQ3 ’20: $2.8BQ4 ’20: $2.2BQ1 ’21: $4.4BQ1 ’21Q2 ’21: $5.6BQ3 ’21: $5.9BQ4 ’21: $6.1BQ1 ’22: $5.2BQ1 ’22Q2 ’22: $5.7BQ3 ’22: $5.8BQ4 ’22: $5.7BQ1 ’23: $6.9BQ1 ’23Q2 ’23: $6.9BQ3 ’23: $6.5BQ4 ’23: $7.3BQ1 ’24: $7.5BQ1 ’24Q2 ’24: $7.9BQ3 ’24: $6.3BQ4 ’24: $7.3BQ1 ’25: $6.7BQ1 ’25Q2 ’25: $5.8BQ3 ’25: $6.7BQ4 ’25: $8.4BQ1 ’26: $5.6BQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 74.9%ETP: 14.5%Other: 10.6%
  • Common Stock · 74.9% · $1.2B
  • ETP · 14.5% · $235M
  • Other · 10.6% · $171M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
SPDR S&P 500 ETF TRNEW+6.0K6.0K+$155M$155M
ISHARES TRNEW+7.0K7.0K+$80M$80M
CERECOR INCNEW+28.16M28.16M+$70M$70M
SUPNSUPERNUS PHARMACEUTICALS INCNEW+3.00M3.00M+$54M$54M
VNDAVANDA PHARMACEUTICALS INCNEW+4.57M4.57M+$47M$47M
AMZNAMAZON COM INCNEW+23.0K23.0K+$45M$45M
VXRTVAXART INCNEW+25.20M25.20M+$45M$45M
BURLBURLINGTON STORES INCNEW+258.0K258.0K+$41M$41M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

47 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CERECOR INCCOM4.32%$70M28.16M
2SUPNSUPERNUS PHARMACEUTICALS INChistory →COM3.34%$54M3.00M
3VNDAVANDA PHARMACEUTICALS INChistory →COM2.93%$47M4.57M
4AMZNAMAZON COM INChistory →COM2.77%$45M23.0K
5VXRTVAXART INChistory →COM NEW2.76%$45M25.20M
6BURLBURLINGTON STORES INChistory →COM2.53%$41M258.0K
7INCYINCYTE CORPhistory →COM2.39%$39M528.0K
8ALXNALEXION PHARMACEUTICALS INChistory →COM2.38%$38M428.0K
9CENTACENTRAL GARDEN & PET COhistory →CL A NON-VTG2.37%$38M1.50M
10BMYBRISTOL-MYERS SQUIBB COhistory →COM2.23%$36M648.0K
11BIOHAVEN PHARMACTL HLDG CO LCOM2.22%$36M1.06M
12REGNREGENERON PHARMACEUTICALShistory →COM1.93%$31M64.0K
13DBXDROPBOX INChistory →CL A1.89%$31M1.69M
14DECKDECKERS OUTDOOR CORPhistory →COM1.89%$30M227.5K
15BLUEBIRD BIO INCCOM1.84%$30M648.0K
16KHCKRAFT HEINZ COhistory →COM1.84%$30M1.20M
17ENTAENANTA PHARMACEUTICALS INChistory →COM1.81%$29M568.0K
18PTCTPTC THERAPEUTICS INChistory →COM1.66%$27M600.0K
19ENRENERGIZER HLDGS INC NEWhistory →COM1.63%$26M872.0K
20AMAGAMAG PHARMACEUTICALS INChistory →COM1.57%$25M4.12M
21DGDOLLAR GEN CORP NEWhistory →COM1.55%$25M165.6K
22MRTXEURMIRATI THERAPEUTICS INChistory →COM1.48%$24M312.0K
23FIVEFIVE BELOW INChistory →COM1.46%$24M334.6K
24MRKMERCK & CO. INChistory →COM1.43%$23M300.0K
25CVSCVS HEALTH CORPhistory →COM1.39%$22M378.0K
26DLTRDOLLAR TREE INChistory →COM1.39%$22M305.2K
27FTDRFRONTDOOR INChistory →COM1.38%$22M640.0K
28PFEPFIZER INChistory →COM1.37%$22M678.0K
29CPBCAMPBELL SOUP COhistory →COM1.36%$22M478.0K
30UNHUNITEDHEALTH GROUP INChistory →COM1.36%$22M88.0K
31CN2CATALYST PHARMACEUTICALS INChistory →COM1.29%$21M5.40M
32VYGRVOYAGER THERAPEUTICS INChistory →COM1.27%$20M2.24M
33EPCEDGEWELL PERS CARE COhistory →COM1.19%$19M800.0K
34BIIBBIOGEN INChistory →COM1.13%$18M58.0K
35LNTHLANTHEUS HLDGS INChistory →COM1.04%$17M1.32M
36DYHTARGET CORPhistory →COM1.03%$17M180.0K
37MDLZMONDELEZ INTL INChistory →CL A0.93%$15M300.0K
38ATRAPTARGROUP INChistory →COM0.92%$15M150.0K
39MDGLMADRIGAL PHARMACEUTICALS INChistory →COM0.89%$14M216.0K
40CRICARTERS INChistory →COM0.87%$14M215.0K
41VVISA INChistory →COM CL A0.87%$14M87.0K
42AVYAUSDAVAYA HLDGS CORPhistory →COM0.80%$13M1.59M
43CLCOLGATE PALMOLIVE COhistory →COM0.74%$12M180.0K
44KMBKIMBERLY CLARK CORPhistory →COM0.70%$11M88.0K
45CMGCHIPOTLE MEXICAN GRILL INChistory →COM0.68%$11M16.8K
46ASSEMBLY BIOSCIENCES INCCOM0.66%$11M724.0K
47TWNKEURHOSTESS BRANDS INChistory →CL A0.66%$11M1.00M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$5.6B267May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$8.4B370Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$6.7B332Nov 17, 202513F-HRchanges · EDGAR ↗
Q2 2025$5.8B210Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$6.7B230May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$7.3B232Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$6.3B259Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$7.9B254Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$7.5B337May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$7.3B297Feb 13, 202413F-HRchanges · EDGAR ↗
Q3 2023$6.5B254Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$6.9B222Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$6.9B226May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$5.7B193Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$5.8B197Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$5.7B176Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$5.2B141May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$6.1B145Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$5.9B139Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$5.6B116Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$4.4B111May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$2.2B104Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$2.8B101Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$2.3B79Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$1.6B79May 15, 202013F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • Armistice Capital Master Fund Ltd.028-16739

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.